Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Mar;6(3):223-235.
doi: 10.1016/j.trecan.2020.01.009. Epub 2020 Feb 3.

Glioblastoma Stem Cells: Driving Resilience through Chaos

Affiliations
Review

Glioblastoma Stem Cells: Driving Resilience through Chaos

Briana C Prager et al. Trends Cancer. 2020 Mar.

Abstract

Glioblastoma is an aggressive and heterogeneous tumor in which glioblastoma stem cells (GSCs) are at the apex of an entropic hierarchy and impart devastating therapy resistance. The high entropy of GSCs is driven by a permissive epigenetic landscape and a mutational landscape that revokes crucial cellular checkpoints. The GSC population encompasses a complex array of diverse microstates that are defined and maintained by a wide variety of attractors including the complex tumor ecosystem and therapeutic intervention. Constant dynamic transcriptional fluctuations result in a highly adaptable and heterogeneous entity primed for therapy evasion and survival. Analyzing the transcriptional, epigenetic, and metabolic landscapes of GSC dynamics in the context of a stochastically fluctuating tumor network will provide novel strategies to target resistant populations of GSCs in glioblastoma.

Keywords: cancer stem cell; entropy; glioblastoma; heterogeneity; therapy resistance; tumor evolution.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.. Attractor state model of glioblastoma.
GSCs at the center of the tumor hierarchy have the highest entropy and capacity for adaptation. Attractor states (e.g. microenvironmental niches, genetic mutations, therapeutic intervention) drive the development of different tumor cell populations. Each colored petal depicts different attractor states which drives the proportion of each cellular state. Arrow on the different cellular state represent the directionality allowed on presence of attractor state. Abbreviations: GSC, glioblastoma stem cell
Figure 2.
Figure 2.. Glioblastoma stem cells across tumor niches.
GSCs are found in each tumor microenvironments and maintain heterogeneity through unique cell-cell interactions and niche properties throughout the tumor. These niches are not stable and independent, but instead are dynamic drivers of cellular adaptation and resistance, communicating and interconverting as the tumor grows and adapts. Abbreviations: GSC, glioblastoma stem cell
Figure 3.
Figure 3.. Therapeutic approach to glioblastoma stem cell adaptation and heterogeneity.
i) Classical therapeutic approaches often spare the GSC population or target individual components of the tumor landscape – e.g. tumor vasculature or rapidly dividing cell populations. This generates new attractor states along with the older untreated states and allows for the tumor to evolve and repopulate. ii) The attractor state model implies that effective therapy will require a combinatorial approach. The first treatment bottlenecks tumor adaptation by applying an initial stimulus that drives cells towards one state, and the second intervention is targeted at the resulting specific cellular state. Abbreviations: GSC, glioblastoma stem cell

References

    1. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJB, et al. Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma. N Engl J Med. 2005. Mar 10;352(10):987–96. - PubMed
    1. Omuro A. Glioblastoma and Other Malignant Gliomas: A Clinical Review. JAMA. 2013. Nov 6;310(17):1842. - PubMed
    1. Wang J, Cazzato E, Ladewig E, Frattini V, Rosenbloom DIS, Zairis S, et al. Clonal evolution of glioblastoma under therapy. Nat Genet. 2016. Jun 6;48(7):768–76. - PMC - PubMed
    1. Hanahan D, Weinberg RA. Hallmarks of Cancer: The Next Generation. Cell. 2011. Mar;144(5):646–74. - PubMed
    1. Wang Q, Hu B, Hu X, Kim H, Squatrito M, Scarpace L, et al. Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment. Cancer Cell. 2017. Jul;32(1):42–56.e6. - PMC - PubMed

Publication types

Substances